Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae

Clinical trial NCT02326610 · UNKNOWN

Trial details

NCT number: NCT02326610
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Infant, Small for Gestational Age Growth Hormone Treatment Infant, Premature, Diseases

Start date: 2014-12-01
Primary completion: 2017-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.